Stock News

Exploratory Relationship Will Assess and Develop Mutually Beneficial Processes for the Recovery of Waste Asphalt Shingle Material and Oil WOODS CROSS, Utah, Oct. 15, 2024 (GLOBE NEWSWIRE) Sky Quarry Inc. (NASDAQ: SKYQ) (“Sky Quarry” or the “Company”), an oil production, refining, and development-stage environmental remediation company formed to deploy technologies to facilitate the recycling of…

New Corporate Name & Stock Symbol [BCHT] Reflects Birchtech’s Technological Capacity A Fresh Start for Midwest Energy Emissions Corp. Midwest Energy Emissions Corp., a leading environmental technologies firm, is undergoing a major transformation. The company has announced its rebranding to “Birchtech” and will now operate under the new corporate name of “Birchtech Corp.” This exciting…

Get Ready to Laugh Your Way Through Financial Results Life Time Group Holdings Releases Hilarious Financial Report Alright, buckle up folks, because Life Time Group Holdings, Inc. just dropped the most entertaining financial report you’ll ever read. I know what you’re thinking, “financial reports? who cares!” But trust me, this one is a rollercoaster of…

Breaking News: FDA Approves Annovis for Pivotal Phase 3 Alzheimer’s Studies, Bringing NDA Approval Within Reach MALVERN, Pa., Oct. 15, 2024 (GLOBE NEWSWIRE) — via IBN – Annovis Bio Inc. (NYSE: ANVS) (“Annovis” or the “Company”), a late-stage clinical drug platform company developing transformative therapies for neurodegenerative disorders such as Alzheimer’s disease (AD) and Parkinson’s…

Celebrating a New Venture in Northern British Columbia Introduction to West Mining Corp’s Latest Endeavor In a recent development, West Mining Corp. has secured an option agreement with ESN Investment Corp. This agreement paves the way for West to potentially acquire a 100% interest in two mineral claims located in Northern British Columbia. These claims…

New Data Shows Promising Results from Altimmune’s Pemvidutide Treatment Overview Altimmune, Inc. has recently announced new data that demonstrates reductions of multiple classes of atherogenic and cardio-inflammatory lipids in subjects treated with pemvidutide. This exciting development will be presented at The Liver Meeting® 2024 of the American Association for the Study of Liver Diseases (AASLD)…

Welcome to the Pharmacy Revolution Unveiling the Rx Report: Transforming Community Pharmacy High Demand for Pharmacy Care According to the recent CVS Health/Morning Consult survey, there is a high demand for pharmacy care among consumers. In fact, 76% of consumers have at least one prescription for themselves or a person they care for. This staggering…

Jazz Announces Positive Phase 3 Results for Combination Therapy Charmingly eccentric, full of personality, and designed for maximum reader engagement Jazz Pharmaceuticals plc (Nasdaq: JAZZ) has recently announced positive top-line results from a Phase 3 clinical trial evaluating Zepzelca® (lurbinectedin) in combination with the PD-L1 inhibitor atezolizumab (Tecentriq®) for the treatment of extensive-stage small cell…